Literature DB >> 26865707

Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.

Bjoern Meyer1, Hinh Ly2.   

Abstract

Mammalian arenaviruses are zoonotic viruses that cause asymptomatic, persistent infections in their rodent hosts but can lead to severe and lethal hemorrhagic fever with bleeding and multiorgan failure in human patients. Lassa virus (LASV), for example, is endemic in several West African countries, where it is responsible for an estimated 500,000 infections and 5,000 deaths annually. There are currently no FDA-licensed therapeutics or vaccines available to combat arenavirus infection. A hallmark of arenavirus infection (e.g., LASV) is general immunosuppression that contributes to high viremia. Here, we discuss the early host immune responses to arenavirus infection and the recently discovered molecular mechanisms that enable pathogenic viruses to suppress host immune recognition and to contribute to the high degree of virulence. We also directly compare the innate immune evasion mechanisms between arenaviruses and other hemorrhagic fever-causing viruses, such as Ebola, Marburg, Dengue, and hantaviruses. A better understanding of the immunosuppression and immune evasion strategies of these deadly viruses may guide the development of novel preventative and therapeutic options.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26865707      PMCID: PMC4810556          DOI: 10.1128/JVI.03049-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  103 in total

1.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

Review 3.  Hantaviruses: immunology, treatment, and prevention.

Authors:  Piet Maes; Jan Clement; Irina Gavrilovskaya; Marc Van Ranst
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

Review 4.  Rift Valley fever virus.

Authors:  Ramon Flick; Michèle Bouloy
Journal:  Curr Mol Med       Date:  2005-12       Impact factor: 2.222

5.  Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Elina I Zúñiga; Debralee Rosario; Adolfo García-Sastre; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever.

Authors:  S Mahanty; D G Bausch; R L Thomas; A Goba; A Bah; C J Peters; P E Rollin
Journal:  J Infect Dis       Date:  2001-05-11       Impact factor: 5.226

7.  Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.

Authors:  Maria Montoya; Matthew J Edwards; Delyth M Reid; Persephone Borrow
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

Review 8.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

9.  Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).

Authors:  Robert Eichler; Thomas Strecker; Larissa Kolesnikova; Jan ter Meulen; Winfried Weissenhorn; Stephan Becker; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  Virus Res       Date:  2004-03-15       Impact factor: 3.303

Review 10.  Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics.

Authors:  Shelan Liu; Chengliang Chai; Chengmin Wang; Said Amer; Huakun Lv; Hongxuan He; Jimin Sun; Junfen Lin
Journal:  Rev Med Virol       Date:  2013-12-06       Impact factor: 6.989

View more
  24 in total

1.  Arenaviral Nucleoproteins Suppress PACT-Induced Augmentation of RIG-I Function To Inhibit Type I Interferon Production.

Authors:  Yuying Liang; Hinh Ly; Junjie Shao; Qinfeng Huang; Xiaoying Liu; Da Di
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

2.  Recombinant Tri-Segmented Pichinde Virus as a Novel Live Viral Vaccine Platform.

Authors:  Rekha Dhanwani; Hinh Ly; Yuying Liang
Journal:  Methods Mol Biol       Date:  2017

3.  Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.

Authors:  Hector Moreno; Rebecca Möller; Chiara Fedeli; Gisa Gerold; Stefan Kunz
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.

Authors:  Lei-Ke Zhang; Qi-Lin Xin; Sheng-Lin Zhu; Wei-Wei Wan; Wei Wang; Gengfu Xiao
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

Review 5.  Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.

Authors:  Martin Panigaj; M Brittany Johnson; Weina Ke; Jessica McMillan; Ekaterina A Goncharova; Morgan Chandler; Kirill A Afonin
Journal:  ACS Nano       Date:  2019-11-05       Impact factor: 15.881

6.  Virulence profile: Hinh Ly.

Authors:  Hinh Ly
Journal:  Virulence       Date:  2016-07-14       Impact factor: 5.882

7.  Arenaviral vaccine vectors to combat infectious diseases.

Authors:  Rekha Dhanwani; Hinh Ly
Journal:  Oncotarget       Date:  2016-07-19

Review 8.  Differential Immune Responses to New World and Old World Mammalian Arenaviruses.

Authors:  Hinh Ly
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

9.  Uniquely conserved immunosuppressive viral exoribonucleases.

Authors:  Bjoern Meyer; Hinh Ly
Journal:  Oncotarget       Date:  2017-01-24

10.  Ancient Evolution of Mammarenaviruses: Adaptation via Changes in the L Protein and No Evidence for Host-Virus Codivergence.

Authors:  Diego Forni; Chiara Pontremoli; Uberto Pozzoli; Mario Clerici; Rachele Cagliani; Manuela Sironi
Journal:  Genome Biol Evol       Date:  2018-03-01       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.